Trial site
K2 MEDICAL Research THE VILLAGES
- 16running trials
- 3closed trials
The trials here
What the 19 trials at this site are about, from their registry records.
- Conditions
- Alzheimer disease16 trials
- Mild cognitive impairment2 trials
- Osteoarthritis2 trials
- Fatty liver disease (MASLD/MASH)1 trial
- Phase
- Phase 37 trials
- Phase 16 trials
- Phase 23 trials
- Phase 1/21 trial
- Phase 2/31 trial
- Status
- Recruiting7 trials
- Active, not recruiting4 trials
- Not yet recruiting4 trials
- Terminated3 trials
- Enrolling by invitation1 trial
- Lead sponsor
- Eli Lilly and Company10 trials
- Hoffmann-La Roche3 trials
- Alzheimer's Disease Expert Lab (ADEL), Inc.1 trial
- Asceneuron S.A.1 trial
- Bristol-Myers Squibb1 trial
- and 3 more
Running trials
Recruiting
A Study of LY4405094 in Healthy Participants and Participants With Alzheimer's Disease
Recruiting
A Study of LY4560736 in Healthy Participants and Participants With Alzheimer's Disease (AD)
Recruiting
Recruiting
A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Osteoarthritis Pain
Recruiting
A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
Recruiting
A Study of LY3439539 in Participants With Alzheimer's Disease
Recruiting
Active, not recruiting
A Study of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease
Recruiting
Recruiting
Recruiting
A Study of LY4006895 in Healthy Participants With Early Symptomatic Alzheimer's Disease (AD)
Active, not recruiting
A Study of Remternetug (LY3372993) in Early Alzheimer's Disease (TRAILRUNNER-ALZ 3)
Enrolling by invitation
Active, not recruiting
Active, not recruiting
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Alzheimer disease9 recruiting
- Osteoarthritis2 recruiting
- Fatty liver disease (MASLD/MASH)1 recruiting
- Mild cognitive impairment1 recruiting
Closed trials
Terminated
Terminated
Terminated
Piromelatine 20 mg in Participants With Mild Dementia Due to Alzheimer's Disease
Site data: ClinicalTrials.govUpdated 19 Nov 2026